StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note released on Saturday. The firm issued a hold rating on the software maker’s stock.
Veradigm Trading Down 1.2 %
NASDAQ:MDRX opened at $11.11 on Friday. The firm’s fifty day moving average price is $9.51 and its two-hundred day moving average price is $9.27. Veradigm has a one year low of $5.01 and a one year high of $13.22.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- Canadian Penny Stocks: Can They Make You Rich?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- 3 Tickers Leading a Meme Stock Revival
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What is Put Option Volume?
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
